Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Oral Ganciclovir in the Prevention of Cytomegalovirus Infection in Postkidney Transplant “CMV at Risk” Recipients: A Controlled, Comparative Study of Two Regimens (750 mg Bid and 500 mg Bid)

PaperCitations, authors & open-access status

Oral Ganciclovir in the Prevention of Cytomegalovirus Infection in Postkidney Transplant “CMV at Risk” Recipients: A Controlled, Comparative Study of Two Regimens (750 mg Bid and 500 mg Bid) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 22 citations, 1998 year and closed oa status.

22
Citations
1998
Year
closed
OA Status

Related on ScholarIQ

N Ahsan
Author
Cytomegalovirus and herpesvirus research
Topic
Cytomegalovirus and herpesvirus research
Topic
Herpesvirus Infections and Treatments
Topic
Toxoplasma gondii Research Studies
Topic
470M+ articles · free account